PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Brighton and Sussex University Hospitals NHS Trust, Brighton, UK and Brighton and Sussex Medical School, Falmer, UK.\', \'Department of Chemistry, University of Cambridge, Cambridge, UK.\', \'Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\', \'Brighton and Sussex Medical School, Falmer, UK and Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\', \'Brighton and Sussex Medical School, Falmer, UK and consultant haematologist, Royal Sussex County Hospital, Brighton, UK t.chevassut@bsms.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7861/clinmed.2020-0346
?:doi
?:hasPublicationType
?:journal
  • Clinical medicine (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32694169
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all